Researchers
have identified a protein that can help detect the earliest signs of
ovarian cancer which begins in the female organs that produce eggs
(ovaries) and is usually difficult to diagnose because it grows
virtually unseen into the abdominal cavity.
|
Friday, July 29, 2016
Wednesday, July 27, 2016
New crop of robots to vie for space in the operating room Reuters India - 19 minutes ago
New crop of robots to vie for space in the operating room
CHICAGO
|
Even
though many doctors see need for improvement, surgical robots are poised
for big gains in operating rooms around the world.Within
five years, one in three U.S. surgeries - more than double current
levels – is expected to be performed with robotic systems, with surgeons
sitting at computer consoles guiding mechanical arms. Companies
developing new robots also plan to expand their use in India, China and
other emerging markets.
Robotic surgery has been long dominated by pioneer Intuitive Surgical Inc, which has more than 3,600 of its da Vinci machines in hospitals worldwide and said last week the number of procedures that used them jumped by 16 percent in the second quarter compared to a year earlier.
The anticipated future growth - and perceived weaknesses of the current generation of robots - is attracting deep-pocketed rivals, including Medtronic Inc and a startup backed by Johnson & Johnson and Google. Developers of the next wave aim to make the robots less expensive, more nimble and capable of performing more types of procedures, company executives and surgeons told Reuters.
Although surgical robots run an average of $1.5 million and entail ongoing maintenance expenses, insurers pay no more for surgeries that utilize the systems than for other types of minimally-invasive procedures, such as laparoscopy.
Still, most top U.S. hospitals for cancer treatment, urology, gynecology and gastroenterology have made the investment. The robots are featured prominently in hospital marketing campaigns aimed at attracting patients, and new doctors are routinely trained in their use.
Surgical robots are used in hernia repair, bariatric surgery, hysterectomies and the vast majority of prostate removals in the United States, according to Intuitive Surgical data.
Doctors say they reduce fatigue and give them greater precision.
But robot-assisted surgery can take more of the surgeon's time than traditional procedures, reducing the number of operations doctors can perform. That's turned off some like Dr. Helmuth Billy.
Billy was an early adopter of Intuitive's da Vinci system 15 years ago. But equipping its arms with instruments slowed him down. He rarely uses it now.
"I like to do five operations a day," Billy said. "If I have to constantly dock and undock da Vinci, it becomes cumbersome."
SURGEONS' WISH LIST
To gain an edge, new robots will need to outperform laparoscopic surgery, said Dr. Dmitry Oleynikov, who heads a robotics task force for the Society of American Gastrointestinal and Endoscopic Surgeons.
Surgeons told Reuters they want robots to provide a way to feel the body's tissue remotely, called haptic sensing, and better camera image quality.
New systems also will need to be priced low enough to entice hospitals and outpatient surgical centers that have not yet invested in a da Vinci, as well as convince those with established robotic programs to consider a second vendor or switching suppliers altogether.
"That is where competitors can differentiate," said Vik Srinivasan of the Advisory Board Co, a research and consulting firm that advises hospitals.
Developers say they are paying attention. Verb Surgical, the J&J-Google venture that is investing about $250 million in its project, said creating a faster and easier-to-use system is a priority.
Verb also envisions a system that is "always there, always on," enabling the surgeon to use the robot for parts of a procedure as needed, said Chief Executive Scott Huennekens.
Intuitive said it too is looking to improve technology at a reasonable cost, but newcomers will face the same challenges.
"As competitors come in, they are going to have to work within that same framework," CEO Gary Guthart said in an interview.
Device maker Medtronic has said it expects to launch its surgical robot before mid-2018 and will start in India. Others developing surgical robots include TransEnterix Inc and Canada's Titan Medical Inc.
An RBC Capital Markets survey found that U.S. surgeons expect about 35 percent of operations will involve robots in five years, up from 15 percent today.
J&J, which hopes to be second to market with a product from Verb, has said it sees robotics as a multibillion-dollar market opportunity. Huennekens said Verb's surgical robot will differ from another Google robotics effort, the driverless car, in one important aspect.
"There will always be a surgeon there," he said.
(Reporting by Susan Kelly; Editing by Michele Gershberg and Lisa Girion)
Robotic surgery has been long dominated by pioneer Intuitive Surgical Inc, which has more than 3,600 of its da Vinci machines in hospitals worldwide and said last week the number of procedures that used them jumped by 16 percent in the second quarter compared to a year earlier.
The anticipated future growth - and perceived weaknesses of the current generation of robots - is attracting deep-pocketed rivals, including Medtronic Inc and a startup backed by Johnson & Johnson and Google. Developers of the next wave aim to make the robots less expensive, more nimble and capable of performing more types of procedures, company executives and surgeons told Reuters.
Although surgical robots run an average of $1.5 million and entail ongoing maintenance expenses, insurers pay no more for surgeries that utilize the systems than for other types of minimally-invasive procedures, such as laparoscopy.
Still, most top U.S. hospitals for cancer treatment, urology, gynecology and gastroenterology have made the investment. The robots are featured prominently in hospital marketing campaigns aimed at attracting patients, and new doctors are routinely trained in their use.
Surgical robots are used in hernia repair, bariatric surgery, hysterectomies and the vast majority of prostate removals in the United States, according to Intuitive Surgical data.
Doctors say they reduce fatigue and give them greater precision.
But robot-assisted surgery can take more of the surgeon's time than traditional procedures, reducing the number of operations doctors can perform. That's turned off some like Dr. Helmuth Billy.
Billy was an early adopter of Intuitive's da Vinci system 15 years ago. But equipping its arms with instruments slowed him down. He rarely uses it now.
"I like to do five operations a day," Billy said. "If I have to constantly dock and undock da Vinci, it becomes cumbersome."
SURGEONS' WISH LIST
To gain an edge, new robots will need to outperform laparoscopic surgery, said Dr. Dmitry Oleynikov, who heads a robotics task force for the Society of American Gastrointestinal and Endoscopic Surgeons.
Surgeons told Reuters they want robots to provide a way to feel the body's tissue remotely, called haptic sensing, and better camera image quality.
New systems also will need to be priced low enough to entice hospitals and outpatient surgical centers that have not yet invested in a da Vinci, as well as convince those with established robotic programs to consider a second vendor or switching suppliers altogether.
"That is where competitors can differentiate," said Vik Srinivasan of the Advisory Board Co, a research and consulting firm that advises hospitals.
Developers say they are paying attention. Verb Surgical, the J&J-Google venture that is investing about $250 million in its project, said creating a faster and easier-to-use system is a priority.
Verb also envisions a system that is "always there, always on," enabling the surgeon to use the robot for parts of a procedure as needed, said Chief Executive Scott Huennekens.
Intuitive said it too is looking to improve technology at a reasonable cost, but newcomers will face the same challenges.
"As competitors come in, they are going to have to work within that same framework," CEO Gary Guthart said in an interview.
Device maker Medtronic has said it expects to launch its surgical robot before mid-2018 and will start in India. Others developing surgical robots include TransEnterix Inc and Canada's Titan Medical Inc.
An RBC Capital Markets survey found that U.S. surgeons expect about 35 percent of operations will involve robots in five years, up from 15 percent today.
J&J, which hopes to be second to market with a product from Verb, has said it sees robotics as a multibillion-dollar market opportunity. Huennekens said Verb's surgical robot will differ from another Google robotics effort, the driverless car, in one important aspect.
"There will always be a surgeon there," he said.
(Reporting by Susan Kelly; Editing by Michele Gershberg and Lisa Girion)
ADVERTISEMENT
Trending On Reuters
Facebook trounces Wall Street estimates with sharp ad sales growth
Facebook Inc provided more evidence on Wednesday that it can turn eyeballs into profit as the maker of the world's most popular app and social website trounced Wall Street's estimates, sending its shares to an all-time high. Full Article- Samsung Electronics tips 'solid' second-quarter profit on components pickup
- Disappointing earnings revive speculation on Twitter's future
- Nintendo's Mario eyes a Mickey Mouse merchandising makeover
- As iPhone sales stagnate, services promise growth for Apple
- Brazil prosecutor freezes $11.7 million of Facebook funds due to WhatsApp case
ADVERTISEMENT
Reuters Showcase
Reuters India App
Download the Reuters app from the Apple App Store, Google Play and Amazon. Select the India edition from settings. Full CoverageMonday, July 25, 2016
Saturday, July 23, 2016
New
Delhi: A team of researchers may have found a herbal way to fight off
colon cancer. The Saint Louis University scientists showed that a
combination of two plant compounds that have medicinal properties -
curcumin and silymarin - holds promise in ...
This herbal combo packs powerful punch against colon cancer
Last Updated: Sunday, July 24, 2016 - 09:20
New Delhi: A team of researchers may have found a herbal way to fight off colon cancer.
The Saint Louis University scientists showed that a combination of two plant compounds that have medicinal properties - curcumin and silymarin - holds promise in treating the disease. Curcumin is the active ingredient in the spice turmeric, which is present in spicy curry dishes, and silymarin is a component of milk thistle, which has been used to treat liver disease. The researchers and their students studied a line of colon cancer cells in a laboratory model. They found treating the cells initially with curcumin, then with silymarin was more effective in fighting cancer than treating the cells with either phytochemical alone, said corresponding author Uthayashanker Ezekiel. "The combination of phytochemicals inhibited colon cancer cells from multiplying and spreading. In addition, when the colon cancer cells were pre-exposed to curcumin and then treated with silymarin, the cells underwent a high amount of cell death," he noted, adding "Phytochemicals may offer alternate therapeutic approaches to cancer treatments and avoid toxicity problems and side effects that chemotherapy can cause." Scientists next would need to study how the curcumin and silymarin impact the actions of molecules, such as genetic transcription and expression, that cause cells to change, Ezekiel said. Then the compounds would be studied in an animal model, then in humans. The study appears in the Journal of Cancer.
First Published: Sunday, July 24, 2016 - 09:20
comments powered by Disqus
Top Videos
 
|
Subscribe to:
Posts (Atom)